Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma
Authors:
- Parul TandonPTParul Tandon
- Tushar GohelTGTushar Gohel
- Mandy L. CorriganMCMandy L. Corrigan
- Kathleen L. CoughlinKCKathleen L. Coughlin
- Abdullah ShatnaweiASAbdullah Shatnawei
- Soumya ChatterjeeSCSoumya Chatterjee
- Donald F. KirbyDKDonald F. Kirby
- 1 August 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 49 (7) , 559-564
Abstract
Scleroderma (systemic sclerosis) is an autoimmune disease that can affect multiple organ systems. Gastrointestinal (GI) involvement is the most common organ system involved in scleroderma. Complications of GI involvement including gastroesophageal reflux disease, small intestinal bacterial overgrowth, and chronic intestinal pseudoobstruction secondary to extensive fibrosis may lead to nutritional deficiencies in these patients. Here, we discuss pathophysiology, progression of GI manifestations, and malnutrition secondary to scleroderma, and the use of enteral and parenteral nutrition to reverse severe nutritional deficiencies. Increased mortality in patients with concurrent malnutrition in systemic sclerosis, as well as the refractory nature of this malnutrition to pharmacologic therapies compels clinicians to provide novel and more invasive interventions in reversing these nutritional deficiencies. Enteral and parenteral nutrition have important implications for patients who are severely malnourished or have compromised GI function as they are relatively safe and have substantial retrospective evidence of success. Increased awareness of these therapeutic options is important when treating scleroderma-associated malnutrition.Keywords
This publication has 59 references indexed in Scilit:
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2013
- Vascular Disease in Scleroderma: Mechanisms of Vascular InjuryRheumatic Disease Clinics of North America, 2008
- The Many Faces of SclerodermaRheumatic Disease Clinics of North America, 2008
- Robert H. Goetz: the surgeon who performed the first successful clinical coronary artery bypass operationThe Annals of Thoracic Surgery, 2000
- Gastrointestinal motility disorders in sclerodermaArthritis & Rheumatism, 1994
- Sequential dermal microvascular and perivascular changes in the development of sclerodermaThe Journal of Pathology, 1992
- Identification of Collagen Fibrils in Scleroderma SkinJournal of Investigative Dermatology, 1988
- Peripheral neuropathy in course of progressive systemic sclerosisActa Neuropathologica, 1986
- Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.Annals of the Rheumatic Diseases, 1984
- Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLASTJournal of Clinical Investigation, 1974